AGP Wire

AGP

The neonatal intensive care units catheters market is projected to grow from $0.48 billion in 2026 to $0.58 billion by 2030, driven by more preterm births, higher neonatal admissions and expanding NICU capacity.

AGP

Coherent Market Insights will serve as the Official Knowledge Partner and Official Process Advisor for India Health 2026, the Informa Markets healthcare event set for Aug. 21-23 in New Delhi.

AGP

The market for non-invasive cholesterol readers is projected to rise from $1.3 billion in 2025 to $2.63 billion by 2030, driven by cardiovascular disease prevalence, healthcare spending and demand for painless testing.

AGP

The neuroendoscopy market is projected to grow from $0.83 billion in 2026 to $1.09 billion by 2030, according to The Business Research Company.

AGP

The global market for non-PVC IV bags is projected to grow from $2.52 billion in 2026 to $3.8 billion by 2030, driven by demand for safer, more sustainable medical consumables and tighter material-safety rules.

AGP

The neurosurgical robotics market is projected to grow from $4.74 billion in 2026 to $8.04 billion by 2030, according to The Business Research Company.

AGP

The Business Research Company says the nerve monitoring systems market is set to grow from $1.45 billion in 2025 to $1.54 billion in 2026, with demand driven by more complex surgeries and rising focus on nerve protection.

AGP

The Business Research Company projects steady growth in the global neurovascular embolization devices market, driven by rising hemorrhage cases, broader use of neurointerventional procedures and stronger demand for minimally invasive stroke care….

AGP

The Business Research Company says the global neurology monitoring market is set to grow from $7.34 billion in 2026 to $9.08 billion by 2030, fueled by more complex neurological surgeries, rising traumatic brain injuries and wider use of…

AGP

The Business Research Company projects the next-generation oncology devices and solutions market will rise from $16.41 billion in 2025 to $19.46 billion in 2026, then nearly double again to $38.19 billion by 2030. Growth is being driven by higher…

AGP

The Business Research Company says the next-generation in vitro diagnostics market will grow from $117.97 billion in 2025 to $188.69 billion by 2030, driven by precision medicine, genomic testing and point-of-care adoption.

AGP

The global neurostimulation devices market is projected to grow from $6.86 billion in 2025 to $7.64 billion in 2026, as demand rises for treatments for chronic neurological conditions and pain.

AGP

The novel drug delivery systems market is projected to grow from $129.45 billion in 2026 to $187.53 billion by 2030, driven by demand for targeted therapies, biologics and precision medicine.

AGP

The Business Research Company says the global neurology devices market is on track to grow from $20.09 billion in 2025 to $35.94 billion by 2030, driven by rising neurological disease rates, new imaging tools and wider use of minimally invasive…

AGP

The market for non-invasive brain trauma monitoring devices is projected to rise from $10.73 billion in 2026 to $16.71 billion by 2030, according to The Business Research Company.

AGP

The Business Research Company says the nerve conduit market will grow from $2.17 billion in 2026 to $2.99 billion by 2030, driven by more peripheral nerve injuries, neurological disorders and demand for regenerative repair options.

AGP

The nasal splints market is projected to grow from $7.07 billion in 2025 to $10.76 billion by 2030, driven by more nasal and septal surgeries, cosmetic rhinoplasty and demand for minimally invasive procedures.

AGP

The market for neonatal infants enteral feeding devices is projected to grow from $2.23 billion in 2025 to $2.59 billion by 2030, driven by preterm births, NICU demand and broader neonatal care adoption.

AGP

The nephrostomy bags market is projected to rise from $1.16 billion in 2025 to $1.25 billion in 2026, then reach $1.65 billion by 2030, according to The Business Research Company.

AGP

The next-generation sequencing-based molecular diagnostics market is projected to expand from $2.43 billion in 2026 to $3.23 billion by 2030, according to a new report from The Business Research Company.